About Peloton Therapeutics
Peloton Therapeutics is a company based in Dallas (United States) founded in 2010 by Steven McKnight was acquired by Merck in May 2019.. Peloton Therapeutics has raised $242.6 million across 6 funding rounds from investors including Merck, Orbimed and RA Capital. The company has 62 employees as of December 31, 2022. Peloton Therapeutics offers products and services including HIF-2α Inhibitor. Peloton Therapeutics operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Dallas, United States
- Employees 62 as on 31 Dec, 2022
- Founders Steven McKnight
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Peloton Therapeutics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Peloton Therapeutics
Peloton Therapeutics offers a comprehensive portfolio of products and services, including HIF-2α Inhibitor. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets HIF-2α for treating cancer and related conditions
Funding Insights of Peloton Therapeutics
Peloton Therapeutics has successfully raised a total of $242.6M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $150 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series E — $150.0M
-
First Round
First Round
(01 Jun 2010)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Series E - Peloton Therapeutics | Valuation | RA Capital Management | |
| Mar, 2017 | Amount | Series D - Peloton Therapeutics | Valuation |
investors |
|
| Sep, 2016 | Amount | Series D - Peloton Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Peloton Therapeutics
Peloton Therapeutics has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, Orbimed and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Biomedical innovations are transformed into therapies by Vida Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage investments in US life science startups are focused on.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Peloton Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Peloton Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Peloton Therapeutics Comparisons
Competitors of Peloton Therapeutics
Peloton Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Peloton Therapeutics
Frequently Asked Questions about Peloton Therapeutics
When was Peloton Therapeutics founded?
Peloton Therapeutics was founded in 2010.
Where is Peloton Therapeutics located?
Peloton Therapeutics is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Is Peloton Therapeutics a funded company?
Peloton Therapeutics is a funded company, having raised a total of $242.6M across 6 funding rounds to date. The company's 1st funding round was a Series D of $52.4M, raised on Jun 01, 2010.
How many employees does Peloton Therapeutics have?
As of Dec 31, 2022, the latest employee count at Peloton Therapeutics is 62.
What does Peloton Therapeutics do?
Peloton Therapeutics has developed small molecule therapies for life-threatening diseases. Its lead candidate, PT2385, is a HIF-2α inhibitor (completed phase 2 clinical trials) for the treatment of advanced or metastatic clear cell renal cell carcinoma (ccRCC). It is also developing PT2385 in combination with immuno-oncology drugs for the treatment of ccRCC, and for the treatment of solid tumors. The company is a subsidiary of Merck Co.
Who are the top competitors of Peloton Therapeutics?
Peloton Therapeutics's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
What products or services does Peloton Therapeutics offer?
Peloton Therapeutics offers HIF-2α Inhibitor.
Who are Peloton Therapeutics's investors?
Peloton Therapeutics has 16 investors. Key investors include Merck, Orbimed, RA Capital, Driehaus, and The Column Group.